Yumanity Therapeutics - YMTX Short Interest Ratio & Short Volume

Short interest is the volume of Yumanity Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 30th, traders have sold 46,100 shares of YMTX short. Learn More on Yumanity Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. YMTX shares currently have a short interest ratio of 1.0. Learn More on Yumanity Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Yumanity Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Yumanity Therapeutics saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 46,100 shares, a decline of 8.3% from the previous total of 50,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Yumanity Therapeutics: Eledon Pharmaceuticals, Inc. (0.14%), Orgenesis Inc. (1.04%), VistaGen Therapeutics, Inc. (4.14%), Checkpoint Therapeutics, Inc. (3.41%), Monopar Therapeutics Inc. (0.79%), Sigilon Therapeutics, Inc. (0.82%), MEI Pharma, Inc. (3.44%), Leap Therapeutics, Inc. (2.25%), Unicycive Therapeutics, Inc. (0.63%), and Corvus Pharmaceuticals, Inc. (0.94%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.93 billion), Suncor Energy Inc. ($3.50 billion), T. Rowe Price Group, Inc. ($2.29 billion), PG&E Co. ($1.73 billion), Coinbase Global, Inc. ($1.71 billion), Etsy, Inc. ($1.65 billion), Paramount Global ($1.54 billion), Lucid Group, Inc. ($1.50 billion), Old Dominion Freight Line, Inc. ($1.46 billion), and DICK'S Sporting Goods, Inc. ($1.41 billion). View all of the most shorted stocks.

Short selling YMTX is an investing strategy that aims to generate trading profit from Yumanity Therapeutics as its price is falling. YMTX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Yumanity Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of YMTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including YMTX, twice per month. The most recent reporting period available is November, 30 2022.